닫기
검색

Leadership

Novelty Nobility
Sang Gyu Park
Sang Gyu ParkFounder & CEO & CSO
Sang Gyu is the founder and CEO of Novelty Nobility and a senior scientist with 25 years of experience in protein and antibody research. Up to now, he has designed more than 200 antibodies and achieved hands-on knowhow in immunization and affinity maturation, which became the impetus of Novelty Nobility’s pipeline development. Sang Gyu is an incumbent professor of Pharmacy at Ajou University and received a Ph.D. in Pharmacy from Seoul National University. He currently serves as an editorial board member of Scientific Reports.
Jin Cho
Jin ChoChief Finance & Business Officer
Jin leads finance and business activities at Novelty Nobility. He is an experienced professional in fundraising, deal making and operations at a biotech company and is skillful at translating science into business, and vice versa. At Novelty Nobility, Jin is mostly interested in building a corporate culture that woos talented and decent people, while he himself spends most of the time in crunching numbers and reviewing contracts. He received an MBA from MIT Sloan School of Management.
Sun Hwa Lee
Sun Hwa LeeVice CSO
Sun-Hwa has approximately 30 years of bio-related research experience. Prior to her tenure at Novelty Nobility, Sun-Hwa held a variety of cross-functional drug development roles in which she led the biological aspects of small molecule & PROTAC drug discovery for therapeutics against cancer and other diseases. Sun-Hwa holds a Ph.D. from the Boston University School of Medicine and trained as a research fellow and instructor at Harvard Medical School. In her free time, she loves staying active through hiking and yoga.
Suk Bong Hwang
Suk Bong HwangHead Of General Administration
Sukbong began his career in accounting in the mid 90’s and since then has worked for 25 years in general administration. He has accumulated hands-on general operation experience in many companies from start-ups to mid-sized manufacturing companies and feels rewarded through supporting the company's business successes. Trust and responsibility are his lifetime motto, and he is equipped with fatigueless physical strength and unbreakable mental health. No one has ever beaten him in drinking and golf yet.
Gong Sung
Gong SungHead of CMC
Gong is a biopharmaceutical expert with around two decades of experience in CMC development of antibody and protein therapeutics. Previously at Dong-A ST and CKD, he led the development of biosimilar products of second-generation EPO and wet AMD treatment, with a responsibility to submit product approval data to the South Korean regulatory authority (MFDS). He received a master’s degree from Sungkyunkwan University and is currently pursuing a doctorate degree at its graduate school. In his words, all projects currently underway at Novelty Nobility under his name are expected to be “SUCCESS”, which is what his Korean name Gong Sung means in English.
Novelty Nobility USA
Arlo McGinn
Arlo McGinnChief Operating Officer
Arlo directs business development and operations for Novelty Nobility’s US headquarters in Boston, Massachusetts. A chemist and PhD pharmacologist by training, Arlo has blended his science background with an entrepreneurial spirit to start and build several biotech companies over his 20-year career. His experience has included working with products across the entire development cycle from the R&D bench all the way to NDA submission readiness and commercial sale. Outside the office Arlo enjoys biking, hiking, and exploring New England with his wife and two daughters.